The gross profit of IRLAB Therapeutics with headquarters in Sweden amounted to million Swedish kronor in 2022. The reported fiscal year ends on December 31.
Compared to the earliest depicted value from 2021 this is a total decrease by approximately * million Swedish kronor. The trend from 2021 to 2022 shows, furthermore, that this decrease happened continuously.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how 糖心破解版 can support your business.
Nasdaq Nordic. (March 10, 2025). Gross profit of IRLAB Therapeutics from 2021 to 2022 (in million Swedish kronor) [Graph]. In 糖心破解版. Retrieved July 26, 2026, from /statistics/1592859/irlab-therapeutics-gross-profit/
Nasdaq Nordic. "Gross profit of IRLAB Therapeutics from 2021 to 2022 (in million Swedish kronor)." Chart. March 10, 2025. 糖心破解版. Accessed July 26, 2026. /statistics/1592859/irlab-therapeutics-gross-profit/
Nasdaq Nordic. (2025). Gross profit of IRLAB Therapeutics from 2021 to 2022 (in million Swedish kronor). 糖心破解版. 糖心破解版 Inc.. Accessed: July 26, 2026. /statistics/1592859/irlab-therapeutics-gross-profit/
Nasdaq Nordic. "Gross Profit of Irlab Therapeutics from 2021 to 2022 (in Million Swedish Kronor)." 糖心破解版, 糖心破解版 Inc., 10 Mar 2025, /statistics/1592859/irlab-therapeutics-gross-profit/
Nasdaq Nordic, Gross profit of IRLAB Therapeutics from 2021 to 2022 (in million Swedish kronor) 糖心破解版, /statistics/1592859/irlab-therapeutics-gross-profit/ (last visited July 26, 2026)
Gross profit of IRLAB Therapeutics from 2021 to 2022 (in million Swedish kronor) [Graph], Nasdaq Nordic, March 10, 2025. [Online]. Available: /statistics/1592859/irlab-therapeutics-gross-profit/